A dietary supplement abolishes age-related cognitive decline in transgenic mice expressing elevated free radical processes

Experimental Biology and Medicine

Volumn 228, Issue 7, 2003, Pages 800-810

  Lemon, J A ^a   Boreham, D R ^a   Rollo, C D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Aging; Cognitive decline; Growth hormone; Insulin like growth factor; Learning; Long term potentiation; Memory; Neuronal signal transduction; Reactive oxygen and nitrogen species; Transgenic growth hormone mice

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOFLAVONOID; CHROMIUM PICOLINATE; COD LIVER OIL; CYANOCOBALAMIN; FOLIC ACID; FREE RADICAL; GARLIC EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUTATHIONE; GREEN TEA EXTRACT; GROWTH HORMONE; LEVACECARNINE; LINSEED OIL; MAGNESIUM; MELATONIN; NICOTINAMIDE; PRASTERONE; PYRIDOXINE; THIAMINE; THIOCTIC ACID; UBIDECARENONE; UNINDEXED DRUG; VITAMIN D; SOMATOMEDIN C; VITAMIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DRUG DESIGN; DRUG FORMULATION; GENOTYPE; HORMONE ACTION; INFLAMMATION; INSULIN SENSITIVITY; LEARNING; LONG TERM POTENTIATION; MATURATION; MITOCHONDRIAL MEMBRANE; MOUSE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; TRANSGENIC MOUSE; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; COGNITION; DRUG EFFECT; FEMALE; INSULIN RESISTANCE; MALE; MAZE TEST; MEMORY; METABOLISM; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ALLIUM SATIVUM; ANIMALIA; GADUS MORHUA; GINKGO BILOBA; MUS MUSCULUS; PANAX GINSENG; ZINGIBER OFFICINALE;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COGNITION; DIETARY SUPPLEMENTS; FEMALE; FREE RADICALS; GROWTH HORMONE; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXIDATIVE STRESS; RATS; SIGNAL TRANSDUCTION; VITAMINS;

EID: 0042969137     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/15353702-0322807-05     Document Type: Article

References (98)

1. Ikegami S. Behavioural impairment in radial-arm maze learning and acetylcholine content of the hippocampus and cerebral cortex in aged mice. Behav Brain Res 65:103-111, 1994.
2. Muller EE, Ed. IGFs in the Nervous System. Milano: Springer-Verlag Italia, 1998.
3. Winocur G, Gagnon S. Glucose treatment attenuates spatial learning and memory deficits of aged rats on tests of hippocampal function. Neurobiol Aging 19:233-241, 1998.
4. Wyss JM, Chambless BD, Kadish I, van Groen T. Age-related decline in water maze learning and memory in rats: strain differences. Neurobiol Aging 21:671-681, 2000.
5. Akiyama H, Barger S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffen WST, Hample H, Hull M, Landreth G, Lue LF, Mrak R, Mackenzie IR, McGeer PL, O'Bannion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Stohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421, 2000.
6. Bartke A, Wright JC, Mattison JA, Ingram DK, Miller RA, Roth GS. Extending the lifespan of long-lived mice. Nature 414:412, 2001.
7. Forster MJ, Sohal BH, Sohal RS. Reversible effects of long-term caloric restriction on protein oxidative damage. J Geront 55A:B522-B529, 2000.
8. Bjorklund LM, Sanchez-Pemaute R, Chung S, Andersson T, Chen IYC, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. PNAS 99:2344-2349, 2002.
9. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 407:963-970, 2000.
10. Bartke A, Cecim M, Tang K, Steger AW, Chandrashekar V, Turyn D. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice. Proc Soc Exp Biol Med 206:345-357, 1994.
11. LeRoith D, Bondy C, Yakar S, Lui JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 22:53-74, 2001.
12. Abbasi AA, Rudman D. Effects of human growth hormone in older adults. In: Shiverick KT, Rosenbloom AL, eds. Human Growth Hormone. Boca Raton: CRC Press, pp121-140, 1995.
13. Costoya JA, Finidori J, Moutoussamy S, Senaris R, Devesa J, Arce VM. Activation of growth hormone receptor delivers an antiapoptotic signal: Evidence for a role of Akt in this pathway. Endocrinology 140:5937-5943, 1999.
14. Kulik G, Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol 18:6711-6718, 1998.
15. Torres-Aleman I. Insulin-like growth factors as mediators of functional plasticity in the adult brain. Horm Metabol Res 31:114-119, 1999.
16. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophysi Acta 1332:F105-F126, 1997.
17. Rollo CD. Growth negatively impacts the life span of mammals. Evol Develop 55:55-61, 2002.
18. Rollo CD, Ko CV, Tyerman JGA, Kajiura L, The growth hormone axis and cognition: empirical results and integrated theory derived from giant transgenic mice. Can J Zoo 77:1874-1890, 1999.
19. Lachmansingh EI, Rollo CD. Evidence for a tradeoff between growth and behavioural activity in giant "supermice" genetically engineered with extra growth hormone genes. Can J Zool. 72:2158-2168, 1994.
20. Hajdu I, Obal F Jr, Fang J, Krueger JM, Rollo CD. Sleep of transgenic mice producing excess rat growth hormone. Am J Physiol 282:R70-R76, 2002.
21. Rollo CD, Foss J, Lachmansingh EI, Singh R. Behavioural rhythmicity in transgenic growth hormone mice: tradeoffs, energetics, and sleep-wake cycles. Can J Zoo 75:1020-1034, 1997.
22. Rollo CD, Kajiura L, Wylie B, D'Souza S. The growth hormone axis, feeding, and central allocative regulation: lessons from giant transgenic growth hormone mice. Can J Zoo 77:1873, 1999.
23. Meliska CJ, Burke PA, Bartke A, Jensen RA. Inhibitory avoidance and appetitive learning in aged normal mice: comparison with transgenic mice having elevated plasma growth hormone levels. Neurobiol Learn Mem 68:1-12, 1997.
24. Meliska CJ, Bartke A, Vandergruff JL, Jensen RA. Ethanol and nicotine consumption and preference in transgenic mice overexpressing the bovine growth hormone gene. Pharmacol Biochem Behav 50:563-570, 1995.
25. Bohlooly-y M, Ola B, Gritli-Linde A Barbato C, Isaksson OGP, Ohlsson C, Soderpalm B, Tornell J. Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms. Endocrinology 142:4560-4567, 2001.
26. Soderpalm B, Ericson M, Bohlooly-y M, Engel JA, Tornell J. Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry. Endocrinology 140:5619-5625, 1999.
27. Liu J, Atamna H, Kuratsune H, Ames BN. Delayed brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann NY Acad Sci 959:133-166, 2002a.
28. Liu J, Killilea DW, Ames BN. Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-α-lipoic acid. PNAS 99:1876-1881, 2002b.
29. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc Natl Acad Sci USA 99:2356-2361, 2002c.
30. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 78:547-581, 1998.
31. Rollo CD, Carlson J, Sawada M. Accelerated aging of giant transgenic growth hormone mice is associated with elevated free radical processes. Can J Zoo 74:606-620, 1996.
32. Hauck SJ, Bartke A. Free radical defenses in the liver and kidney of human growth hormone transgenic mice: possible mechanisms of early mortality. J Geront 56A:B153-B162, 2001.
33. Bollano E, Omerovic E, Bohlooly YM, Kujacic V, Madhu B, Tornell J, Isaksson O, Soussi B, Schulze W, Fu MXL, Matejka G, Waagstein F, Isgaard J. Impairment of cardiac function and bioenergetics in adult transgenic mice over-expressing the bovine growth hormone gene. Endocrinology 141:2229-2235, 2000.
34. Edamatsu R, Mori A, Packer L. The spin-trap N-tert-alpha-phenylbutylnitrone prolongs the life-span of the senescence accelerated mouse. Biochem Biophys Res Commun 211:847-849, 1995.
35. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC. Mitochondrial disease in mouse results in increased oxidative stress. PNAS 96:4820-4825, 1999.
36. Thiels E, Urban NN, Gonzalez-Burgos GR, Kanterewicz BI, Barrionuevo G, Chu CT, Oury TD, Klann E. Impairment of long-term potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J Neurosci 20:7631-7639, 2000.
37. Kinney BA, Coschigano KT, Kopchick JJ, Steger RW, Bartke A. Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice. Physiol Behav 72:653-660, 2001.
38. Kinney BA, Meliska CJ, Steger RW, Bartke A. Evidence that Ames dwarf mice age differently from their normal siblings in behavioural and learning and memory parameters. Horm Behav 39:277-284, 2001.
39. Finch CE, Ruvkun G. The genetics of aging. Annu Rev Genom Hum Genet 2:435-462, 2001.
40. Dominici FB, Turyn D. Growth hormone-induced alterations in the insulin-signaling system. Proc Soc Exp Biol Med 227:149-157, 2002.
41. Atkins CM, Sweatt JD. Reactive oxygen species mediate activity-dependent neuron-glia signalling in output fibers of the hippocampus. J Neurosci 19:7241-7248, 1999.
42. Knapp LT, Klann E. Potentiation of hippocampal synaptic transmission by superoxide requires the oxidative activation of protein kinase C. J Neurosci 22:674-683, 2002.
43. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol 279:L1005-L1028, 2000.
44. Ziegler D, Hanefeld M, Ruhnau KJ, Meibner HP, Lobisch M, Schutte K, Gries FA. the ALADIN study group. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 38:1425-1433, 1995.
45. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress: The EVA study. J Am Geriatric Soc 48:1285-1291, 2000.
46. Carney JM, Starke-Reed PE, Oliver CN, Landum AW, Cheng MS, Wu JF, Floyd RA. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone. Proc Natl Acad Sci USA 88:3633-3636, 1991.
47. Hagen TM, Ingersoll RT, Lykkesfeld J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, Ames BN. R-α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J 13:411-418, 1999.
48. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA 99:1870-1875, 2002.
49. Atamna H, Robinson C, Ingersoll R, Elliott H, Ames BN. N-t-butyl hydroxylamine is an antioxidant that reverses age-related changes in mitochondria in vivo and in vitro. FASEB J 15:2196-2204, 2001.
50. Melov S. Therapeutics against mitochondrial oxidative stress in animal models of aging. Ann NY Acad Sci 959:330-340, 2002.
51. Foley DJ, White LR. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:3261-3263, 2002.
52. x. FEBS Lett 436:387-389, 1998.
53. Palmiter RD, Brinster RL, Hammer RE. Dramatic growth of mice that develop from eggs microinjected with metallothionien-growth hormone fusion genes. Nature 300:611-615, 1982.
54. Calder WA. Size, Function and Life History. Cambridge:, Harvard University Press, pp431, 1994.
55. Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol 21:330-338, 2000.
56. Shea BT, Hammer RE, Brinster RL. Growth allometry of the organs in giant transgenic mice. Endocrinology 121:1924-1930, 1987.
57. O'Kusky JR, Ye P, D'Ercole J. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J Neurosci 20:8435-8442, 2000.
58. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F. IGF-I gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14:717-730, 2000.
59. Lathe R. Hormones and the hippocampus. J Endocrinol 169:205-231, 2001.
60. Aberg MAI, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20:2896-2903, 2000.
61. Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-375, 2001.
62. Steger RW, Bartke A, Cecim M. Premature aging in transgenic mice expressing different growth hormone genes. J Reprod Fert 46:61-75, 1993.
63. Sara VR, Carlsson-Skurirut C, Bergman T, Jornvall H, Roberts PJ, Crawford M, Hakansson LN, Civalero I, Nordberg A. Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor I which is truncated in brain as a novel neuroactive peptide. Biochem Biophys Res Commun 165:766-771, 1989.
64. 3H-dihydromorphine from rat brain opioid receptors. J Endocrin Invest 12(5 suppl. 2):140, 1989.
65. A receptor complex. Eur J Pharmacol 344:R1-R2, 1998.
66. Stickgold R, Hobson JA, Fosse R, Fosse M. Sleep, learning, and dreams: off- line memory reprocessing. Science 294:1052-1057, 2001.
67. Adams JP, Sweatt JD. Molecular psychology: Roles for the ERK MAP kinase cascade in memory. Ann Rev Pharmacol Toxicol 42:135-163, 2002.
68. Ramm P, Smith CT. Rates of cerebral protein synthesis are linked to slow wave sleep in the rat. Physiol Behav 48:749-753, 2000.
69. Diaz-Torga G, Feierstein C, Libertun C Gelman D, Kelly MA, Low MJ, Rubinstein M, Becu-Villalobos D. Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology 143:1270-1279, 2002.
70. Nilsson L, Mohammed AKH, Henriksson BG, Folkesson R, Winbald B, Bergstrom L. Environmental influence on somatostatin levels and gene expression in the rat brain. Brain Res 628:93-98, 1993.
71. Laakmann G, Zygan K, Schoen HW, Weiss A, Wittmann M, Meissner R, Blaschke D. Effect of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans-I. Growth hormone. Psychoneuroendocrinology 11-447-461, 1996.
72. Perkinton MS, Ip JK, Wood GL, Crossthwaste AJ, Williams RJ. Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signaling to MAP kinase (ERKI/2), Akt/PKB and CREB in striatal neurons. J Neurochem 80:239-254, 2002.
73. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76:1-10, 2001.
74. Klann E, Roberson ED, Knapp LT, Sweatt ID. A role for superoxide in protein kinase C activation and induction of long-term potentiation. J Biol Chem 273:4516-4522, 1998.
75. Davis S, Vanhoutte P, Pages C, Caboche J, Laroche S. The MAPK/ ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus In Vivo. J Neurosci 20:4563-4572, 2000.
76. 2L receptor stimulation of the mitogen-activated protein kinase pathway is dependent on trans-activation of the platelet-derived growth factor receptor. Mol Pharmacol 60:92-103, 2001.
77. Dalton TP, Shertzer HG, Puga A. Regulation of gene expression by reactive oxygen species. Annu Rev Pharmacol Toxicol 39:67-101, 1999.
78. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol 279:L1005-L1028, 2000.
79. Noh KM, Koh JY. Induction and activation by zinc of NADPH oxidase in cultured cortical neuron and astrocytes. J Neurosci 20:RC111, 2000.
80. Tammariello SP, Quinn MT, Estus S. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J Neurosci 20:RC53, 2000.
81. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, Thomas GR. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 28:2252-2258, 1997.
82. Klann E. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. J Neurophysiol 80:452-457, 2001.
83. Kanterewicz BI, Knapp LT, Klann E. Stimulation of p42 and p44 mitogen-activated protein kinases by reactive oxygen species and nitric oxide in hippocampus. J Neurochem 70:1009-1016, 1998.
84. Gahtan E, Auerbach JM, Groner Y, Segal M. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur J Neurosci 10:538-544, 1998.
85. Wang X, Culotta VC, Klee CB. Superoxide dismutase protects calcineurin from inactivation. Nature 383:434-437, 1996.
86. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82:47-95, 2001.
87. Skaper SD, Facci L, Strijbos PJLM. Neuronal protein kinase signaling cascades and excitotoxic cell death. Ann NY Acad Sci 939:11-22, 2001.
88. 2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. J Gerontol 55A:B106-B112, 2000.
89. Brown-Borg HM, Rakoczy SG, Romanick MA, Kennedy MA. Effects of growth hormone and insulin-like growth factor-I on hepatocyte antioxidative enzymes. Expt Biol Med 227:94-104, 2002.
90. Geffner M. Effects of growth hormone and insulin-like growth factor I on T- and B-lymphocytes and immune function, Acta Paediatr 423(Suppl):76-79, 1997.
91. Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor-I. Endocrinology 138:3515-3520, 1997.
92. Park CR. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25:311-323, 2001.
93. Casanueva FF, Dieguez C. Interaction between body composition, leptin and growth hormone status. Clin Endocrinol Metab 12:297-314, 1998.
94. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A. Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Proc Soc Exp Biol Med 226:552-558, 2001.
95. Parr T. Insulin exposure and aging theory. Gerontology 43:182-200, 1997.
96. Weinruch R, Keenan KP, Carney JM, Fernandes G, Feuers RJ, Floyd RA, Halter JB, Ramsey JJ, Richardson A, Roth GS, Spindler SR. Caloric restriction mimetics: metabolic interventions. J Gerontol 56A:20-33, 2001.
97. Zs-Nagy I. The Membrane Hypothesis of Aging. Boca Raton, FL: CRC Press, 1994.
98. Paradies G, Petrosillo G, Gadaleta MN, Ruggiero FM. The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett 454:207-209, 1999.